{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-134376","form_type":"8-K","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.585431+00:00","generated_at":"2026-06-02T12:56:09.247132+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Coya Therapeutics stockholders approve 750,000 share increase to equity incentive plan","bullets":["Amendment to 2021 Equity Incentive Plan adds 750,000 shares, raising total authorized to 2,571,070.","Class II directors elected: Anabella Villalobos, Ph.D. and Dov Goldstein, M.D., M.B.A.","Shareholders ratified Weaver and Tidwell, L.L.P. as independent auditor for FY2024.","All three proposals passed with required votes, including broker non-votes on director and plan items."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-134376","json":"https://secwatch.observer/filing/0001193125-24-134376.json","markdown":"https://secwatch.observer/filing/0001193125-24-134376.md","text":"https://secwatch.observer/filing/0001193125-24-134376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312524134376/0001193125-24-134376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312524134376/d837317d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T12:56:09.247132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a29cbffd76f89d8bb635550951d802a53790c5b","claim":"Coya Therapeutics, Inc. shareholders approved Election of two Class II directors.","evidence_excerpt":"The election of Anabella Villalobos, Ph.D. and Dov Goldstein, M.D., M.B.A., as Class II directors to hold office for a term of three years, until their successors are duly elected and qualified or they are otherwise unable to complete their respective terms. The votes were cast for this matter were as follows: Nominee For Withheld Broker Non-Votes Anabella Villalobos, Ph.D. 4,266,152 1,026,654 1,978,147 Dov Goldstein, M.D., M.B.A. 4,078,787 1,214,019 1,978,147","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312524134376/0001193125-24-134376-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}